PYRROLOPYRIMINDINE CDK9 KINASE INHIBITORS
Disclosed are compound of Formula (Ia), wherein R1, R2, and R3 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions, comprising one or more...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
02.10.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!